Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. AMRX
AMRX logo

AMRX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AMRX News

Amneal Pharmaceuticals Reports Strong Q4 2025 Earnings Growth and Strategic Outlook

Feb 27 2026seekingalpha

Amneal Pharmaceuticals Q4 Earnings Beat Expectations with Strong Revenue Growth

Feb 27 2026Benzinga

Amneal Pharmaceuticals Q4 Earnings Exceed Expectations

Feb 27 2026seekingalpha

Amneal Pharmaceuticals Set to Release Q4 Earnings on February 27

Feb 26 2026seekingalpha

Doseology Sciences Launches New Energy Product Line

Feb 13 2026PRnewswire

Doseology Sciences Launches New Energy Product Line

Feb 13 2026Newsfilter

Amneal Pharmaceuticals Settles Majority of Opioid Claims for Up to $267M

Jan 29 2026seekingalpha

Healthcare Stocks Surge in After-Hours Trading

Jan 28 2026NASDAQ.COM

AMRX Events

02/27 06:20
Sees FY26 Revenue at $3.05B-$3.15B
Sees FY26 revenue $3.05B-$3.15B, consensus $3.21B. Sees FY26 adjusted EBITDA $720M-$760M.

AMRX Monitor News

No data

No data

AMRX Earnings Analysis

Amneal Pharmaceuticals Inc Reports Q3 2024 Financial Results
1 years ago

People Also Watch